Vectus Biosystems (ASX:VBS) Pretax Margin %

: -23,766.67% (As of Dec. 2022)

View and export this data going back to 2016. Start your Free Trial

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Vectus Biosystems's Pre-Tax Income for the six months ended in Dec. 2022 was A$-2.14 Mil. Vectus Biosystems's Revenue for the six months ended in Dec. 2022 was A$0.01 Mil. Therefore, Vectus Biosystems's pretax margin for the quarter that ended in Dec. 2022 was -23,766.67%.

The historical rank and industry rank for Vectus Biosystems's Pretax Margin % or its related term are showing as below:

ASX:VBS' s Pretax Margin % Range Over the Past 10 Years
Min: -80316.67 Med: -80316.67 Max: -39822.22
Current: -39822.22

ASX:VBS's Pretax Margin % is ranked worse than
96.38% of 1021 companies
in the Biotechnology industry
Industry Median: -195.63 vs ASX:VBS: -39822.22

Vectus Biosystems Pretax Margin % Historical Data

The historical data trend for Vectus Biosystems's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Pretax Margin %

Vectus Biosystems Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Pretax Margin %										-	-	-	-	-23,766.67

Vectus Biosystems Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Vectus Biosystems's Pretax Margin for the fiscal year that ended in Jun. 2022 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Jun. 2022 )	/	Revenue (A: Jun. 2022 )
	=	-3.994	/	0
	=	%

Vectus Biosystems's Pretax Margin for the quarter that ended in Dec. 2022 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2022 )	/	Revenue (Q: Dec. 2022 )
	=	-2.139	/	0.009
	=	-23,766.67 %

Vectus Biosystems (ASX:VBS) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Vectus Biosystems Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vectus Biosystems (ASX:VBS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018

Website

http://www.vectusbiosystems.com.au

Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines